Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInventory AverageInvested CapitalReturn on AssetsReturn on EquityReturn on Sales

Basel Medical (BMGL) Debt to Equity (2024 - 2025)

Historic Debt to Equity for Basel Medical (BMGL) over the last 2 years, with Q2 2025 value amounting to $0.7.

  • Basel Medical's Debt to Equity rose 2390.75% to $0.7 in Q2 2025 from the same period last year, while for Jun 2025 it was $0.7, marking a year-over-year increase of 2390.75%. This contributed to the annual value of $0.67 for FY2025, which is 1894.94% up from last year.
  • According to the latest figures from Q2 2025, Basel Medical's Debt to Equity is $0.7, which was up 2390.75% from $0.07 recorded in Q4 2024.
  • Basel Medical's Debt to Equity's 5-year high stood at $0.7 during Q2 2025, with a 5-year trough of $0.07 in Q4 2024.